Details for New Drug Application (NDA): 085266
✉ Email this page to a colleague
NDA 085266 describes DI-ATRO, which is a drug marketed by Md Pharm and is included in one NDA. Additional details are available on the DI-ATRO profile page.
The generic ingredient in DI-ATRO is atropine sulfate; diphenoxylate hydrochloride. There are twenty-three drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the atropine sulfate; diphenoxylate hydrochloride profile page.
The generic ingredient in DI-ATRO is atropine sulfate; diphenoxylate hydrochloride. There are twenty-three drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the atropine sulfate; diphenoxylate hydrochloride profile page.
Summary for 085266
| Tradename: | DI-ATRO |
| Applicant: | Md Pharm |
| Ingredient: | atropine sulfate; diphenoxylate hydrochloride |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 0.025MG;2.5MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
